Dr. Oak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Palo Alto, CA 94305Phone+1 650-723-6041Fax+1 650-723-9178
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 2011 - 2015
University of California, Irvine, School of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2012 - 2026- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Blood Banking/Transfusion Medicine
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 51 citationsT Cell Ig and Mucin Domain-1-Mediated T Cell Activation Requires Recruitment and Activation of Phosphoinositide 3-KinaseAnjali J. de Souza, Jean S. Oak, Ryan Jordanhazy, Rosemarie H. DeKruyff, David A. Fruman
Journal of Immunology. 2008-05-15 - 287 citationsCAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trialJay Y. Spiegel, Shabnum Patel, Lori Muffly, Nasheed Hossain, Jean Oak
Nature Medicine. 2021-07-26 - 13 citationsA study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemiaNahid Shahmarvand, Jean Oak, Michael J. Cascio, M. Alcasid, E. Goodman
International Journal of Laboratory Hematology. 2017-08-01
Abstracts/Posters
- Circulating DNA for Molecular Response Prediction, Characterization of Resistance Mechanisms and Quantification of CAR T-Cells during Axicabtagene Ciloleucel TherapyJean Oak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Identification of Dual Positive CD19+/CD3+ T Cells in an Apheresis Product Undergoing Chimeric Antigen Receptor (CAR) TransductionJean Oak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Study Predicts Who May Benefit from CAR-T Cell Therapy for Blood CancersAugust 2nd, 2021- Study Predicts Who May Benefit from CAR-T Cell Therapy for Blood CancersAugust 5th, 2021
- A Coating for Endotracheal Tubes That Releases Antimicrobial PeptidesAugust 5th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
